Company search
Overview
Performance
Portfolio
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Unlisted holdings
| % of total assets |
|---|
| N/R |
Please note that the percentage of unlisted holdings is displayed for companies that have reported this data to the AIC. “N/R” means the data has not been reported to the AIC. Where data is reported, it may be subject to valuation lags.
Top holdings
Data as at : 29/02/2024
| Investment | % of total assets |
|---|---|
| Eli Lilly and Co | 7.3 |
| Zealand Pharma A/S | 5.7 |
| AbbVie Inc | 5.7 |
| Elevance Health Inc | 5.0 |
| Novartis AG Registered Shares | 4.9 |
| Abbott Laboratories | 4.4 |
| Intuitive Surgical Inc | 3.6 |
| Becton Dickinson & Co | 3.5 |
| Essilorluxottica | 3.3 |
| UCB SA | 3.3 |
Geographic breakdown
Data as at : 31/03/2024
| Country | % of total assets |
|---|---|
| USA | 51.0 |
| Switzerland | 10.0 |
| Denmark | 7.0 |
| France | 7.0 |
| Belgium | 4.0 |
| Japan | 4.0 |
| UK | 4.0 |
| Australia | 3.0 |
| Ireland | 3.0 |
| Sweden | 3.0 |
| Netherlands | 2.0 |
| Cayman Islands | 1.0 |
| India | 1.0 |
Depending on the nature of the underlying asset classes, geographic breakdowns may not always add up to 100%.
Industry breakdown
Data as at : 29/02/2024
| Industry | % of total assets |
|---|---|
| Healthcare | 107.9 |
| Cash Equivalents | -7.9 |
Scroll
Asset breakdown
Data as at : 29/02/2024
| Asset | % of total assets |
|---|---|
| Stock | 107.9 |
| Other | 0.0 |
| Cash/Cash equivalents | -7.9 |
Detailed asset breakdown
Data as at : 29/02/2024
| Asset | % of total assets |
|---|---|
| North America - stock | 60.3 |
| Europe - Large-cap stock | 20.8 |
| Europe - Mid-cap stock | 11.2 |
| Japan - stock | 5.1 |
| Asia (excl Japan) - stock | 4.5 |
| UK - Mid core/growth stock | 1.9 |
| UK - Mid core/value stock | 1.6 |
| UK - Small core/growth stock | 1.4 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.
